Tempo differito
Nasdaq
Variaz. 5gg
Var. 1 gen.
- USD
-.--%
+0,14%
-0,05%
Presenter SpeechNavdeep Singh (Analysts)All right. Good afternoon, everyone, and thanks for jo...
Transcript : Novartis AG, The Medicines Company - M&A Call
25/11/19
Transcript : The Medicines Company - Special Call
18/11/19
Transcript : The Medicines Company, Q3 2019 Earnings Call, Oct 30, 2019
30/10/19
Transcript : The Medicines Company - Special Call
02/09/19
Transcript : The Medicines Company, Q2 2019 Earnings Call, Jul 24, 2019
24/07/19
Transcript : The Medicines Company - Special Call
18/05/19
Transcript : The Medicines Company Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 08:00 AM
14/05/19
Transcript : The Medicines Company, Q1 2019 Earnings Call, Apr 25, 2019
25/04/19
Transcript : The Medicines Company, Q4 2018 Earnings Call, Feb 27, 2019
27/02/19
Transcript : The Medicines Company, Q3 2018 Earnings Call, Nov 08, 2018
08/11/18
Transcript : The Medicines Company, Q2 2018 Earnings Call, Aug 01, 2018
01/08/18
Transcript : The Medicines Company, Q1 2018 Earnings Call, Apr 25, 2018
25/04/18
Transcript : The Medicines Company, Q4 2017 Earnings Call, Feb 21, 2018
21/02/18
Transcript : The Medicines Company - Analyst/Investor Day
23/01/18
Transcript : The Medicines Company Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-08-2018 08:30 AM
08/01/18
Transcript : Melinta Therapeutics, Inc., The Medicines Company - M&A Call
29/11/17
Transcript : The Medicines Company, Q3 2017 Earnings Call, Oct 25, 2017
25/10/17
Transcript : The Medicines Company, Q2 2017 Earnings Call, Aug 09, 2017
09/08/17
Transcript : The Medicines Company Presents at Bank of America Merrill Lynch 2017 Healthcare Conference, May-16-2017 08:00 AM
16/05/17
Transcript : The Medicines Company, Q1 2017 Earnings Call, Apr 26, 2017
26/04/17
Transcript : The Medicines Company Presents at 16th Annual Needham Healthcare Conference, Apr-04-2017 08:00 AM
04/04/17
Transcript : The Medicines Company - Special Call
17/03/17
Transcript : The Medicines Company, Q4 2016 Earnings Call, Feb 28, 2017
28/02/17
Transcript : The Medicines Company Presents at 35th Annual JP Morgan Healthcare Conference, Jan-09-2017 07:30 AM
09/01/17
Transcript : The Medicines Company - Special Call
15/11/16
Durata Auto. 2 mesi 3 mesi 6 mesi 9 mesi 1 anno 2 anni 5 anni 10 anni Max.
Periodo Giorno Settimana
Altri grafici
The Medicines Company è un'azienda biofarmaceutica globale. L'Azienda è focalizzata sullo sviluppo di inclisiran, una terapia biennale che consente la somministrazione durante le visite di routine dei pazienti ai loro operatori sanitari e che potenzialmente contribuisce a migliorare l'aderenza dei pazienti e a mantenere livelli di LDL-C più bassi. L'Azienda è una filiale di Novartis AG.
Altre informazioni sulla società
Variaz. 1 gen.
Capi.
-0,05% 6,79 Mrd +23,57% 44,74 Mrd +33,92% 23,36 Mrd +25,28% 16,24 Mrd +20,64% 14,39 Mrd +69,45% 13,96 Mrd -12,90% 6,4 Mrd -8,87% 5,73 Mrd +13,36% 5,68 Mrd +12,06% 4,92 Mrd
Generico Farmaceutico
Miglior portale finanziario
+951% di performance storica
+ di 20 anni al tuo fianco
Cancellazione semplice & veloce
I nostri Esperti al tuo servizio
I NOSTRI ESPERTI AL TUO SERVIZIO
Lunedì-Venerdì 09:00-12:00/14:00-18:00